Elixxer ELIXF Stock
Elixxer Price Chart
Elixxer ELIXF Financial and Trading Overview
Elixxer stock price | 0.0061 USD |
Previous Close | 0.03 USD |
Open | 0.03 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.03 - 0.03 USD |
52 Week Range | 0.03 - 2.1 USD |
Volume | 984 USD |
Avg. Volume | 15 USD |
Market Cap | 10.14M USD |
Beta (5Y Monthly) | 1.141895 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.18 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
ELIXF Valuation Measures
Enterprise Value | 3.97M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 139.36348 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 54.521 |
Enterprise Value/EBITDA | -6.209 |
Trading Information
Elixxer Stock Price History
Beta (5Y Monthly) | 1.141895 |
52-Week Change | -96.17% |
S&P500 52-Week Change | 20.43% |
52 Week High | 2.1 USD |
52 Week Low | 0.03 USD |
50-Day Moving Average | 0.03 USD |
200-Day Moving Average | 0.44 USD |
ELIXF Share Statistics
Avg. Volume (3 month) | 15 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 11.35M |
Float | 7.55M |
Short Ratio | N/A |
% Held by Insiders | 0.10% |
% Held by Institutions | 32.04% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:100 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -880.86% |
Gross Margin | 100.00% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -3.10% |
Return on Equity (ttm) | -340.68% |
Income Statement
Revenue (ttm) | 72.76K USD |
Revenue Per Share (ttm) | 0.006 USD |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -638978 USD |
Net Income Avi to Common (ttm) | -12225539 USD |
Diluted EPS (ttm) | -0.89 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 4.53M USD |
Total Cash Per Share (mrq) | 0.4 USD |
Total Debt (mrq) | 8.12M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.658 |
Book Value Per Share (mrq) | -0.217 |
Cash Flow Statement
Operating Cash Flow (ttm) | -4339897 USD |
Levered Free Cash Flow (ttm) | -2507214 USD |
Profile of Elixxer
Country | United States |
State | QC |
City | Montreal |
Address | 100 Boulevard Rene- Levesque Ouest |
ZIP | H5B 4N4 |
Phone | N/A |
Website | https://www.elixxer.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Elixxer Ltd. operates as a cannabis investment firm in Canada, Australia, Italy, Jamaica, and Switzerland. It invests in cannabis-related businesses, which are fully licensed for cultivation, production, and/or sale of medical and specialty cannabis and cannabis-derived products in the pharmaceutical sector. The company was formerly known as LGC Capital Ltd. and changed its name to Elixxer Ltd. in August 2019. Elixxer Ltd. was incorporated in 2004 and is based in Montreal, Canada.
Q&A For Elixxer Stock
What is a current ELIXF stock price?
Elixxer ELIXF stock price today per share is 0.0061 USD.
How to purchase Elixxer stock?
You can buy ELIXF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Elixxer?
The stock symbol or ticker of Elixxer is ELIXF.
Which industry does the Elixxer company belong to?
The Elixxer industry is Drug Manufacturers-Specialty & Generic.
How many shares does Elixxer have in circulation?
The max supply of Elixxer shares is 1.66B.
What is Elixxer Price to Earnings Ratio (PE Ratio)?
Elixxer PE Ratio is now.
What was Elixxer earnings per share over the trailing 12 months (TTM)?
Elixxer EPS is -0.18 USD over the trailing 12 months.
Which sector does the Elixxer company belong to?
The Elixxer sector is Healthcare.